THE IMPACT OF HEPATITIS C ON THE BRAZILIAN PUBLIC HEALTH SYSTEM: BIBLIOGRAPHIC REVIEW

Abstract

Introduction: Hepatitis C is a chronic disease that represents a significant challenge for the Brazilian Public Health System (SUS) due to its serious complications, such as cirrhosis and hepatocellular carcinoma, and high treatment costs. Brazil, in turn, has implemented public policies to expand access to modern treatments, such as direct-acting antivirals (DAAs), aiming to reduce the impact of this disease. Objective: This study aims to carry out a literature review on the impact of hepatitis C on the SUS, analyzing aspects such as epidemiology, economic impact, public policies and the challenges faced in managing the disease. Methodology: A narrative bibliographic review was carried out, using databases such as PubMed, SciELO, LILACS and Google Scholar. Articles published between 2011 and 2023 were included, which addressed the impact of hepatitis C on the SUS, considering economic,
epidemiological and public policy factors. Result: Data analysis revealed that hepatitis C has a multifaceted impact on the SUS, with high direct and indirect costs. Despite the expansion of access to DAAs, the system faces challenges such as underreporting of cases, regional inequalities in access to treatment and infrastructure difficulties in certain regions. Discussion: The results indicate that although advances in DAA treatment are promising, there is a continued need to improve early diagnosis and monitoring strategies and address regional disparities. The financial sustainability of the treatment is a concern, as is combating stigma related to the disease. Conclusion: The impact of hepatitis C on the SUS is significant and requires an integrated approach, combining therapeutic advances, effective public policies and a more equitable health infrastructure. Only with these efforts will it be possible to reduce
the burden of hepatitis C on the health system and improve the quality of life of patients in Brazil.